Skip to main content

Table 5 Prognostic factors of 5-year overall survival of colorectal cancer in univariate analysis

From: Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival

 

Total (n = 593)

Events (n = 268)

Odds ratio (95% confidence interval)

p

Age, mean (±SD) yrs

69.4 (± 12.2)

72.4 (± 12.3)

1.03 (1.0–1.1)

< 0.0001

Gender, n (%)

 Male

337 (56.8)

157 (58.6)

  

 Female

256 (43.2)

111 (41.4)

0.9 (0.6–1.2)

0.4

Tumor location, n (%)

 Rectum

249 (42.3)

116 (43.8)

  

 Left-sided colon

132 (22.4)

53 (20.0)

0.8 (0.5–1.2)

0.2

 Right-sided colon

208 (35.3)

96 (36.2)

1.0 (0.7–1.4)

0.9

Tumor differentiation, n (%)

 Well & moderate

445 (76.3)

183 (69.8)

  

 Poor

138 (23.7)

79 (30.2)

1.9 (1.3–2.9)

0.001

Stage, n (%)

 I & II

264 (44.8)

78 (29.1)

  

 III

232 (39.3)

105 (39.2)

1.9 (1.4–2.8)

0.0002

 IV

94 (15.9)

85 (31.7)

22.5 (10.8–47.3)

< 0.0001

Lymph node positive, n (%)

 No

268 (45.2)

83 (31.0)

  

 Yes

325 (54.8)

185 (69.0)

2.9 (2.1–4.1)

< 0.0001

Lymph node count, n (%)

  < 12

183 (30.9)

99 (36.9)

  

  ≥ 12

410 (69.1)

169 (63.1)

0.6 (0.4–0.8)

0.001

Radical operation, n (%)

 No

81 (13.8)

77 (29.3)

  

 Yes

506 (86.2)

186 (70.7)

0.03 (0.01–0.1)

< 0.001

Year of surgery, n (%)

 1990–2000

140 (23.6)

80 (29.8)

  

 2001–2006

453 (76.4)

188 (70.2)

0.5 (0.4–0.8)

0.001

XRCC1-rs25487, n (%)

 G/G

250 (42.6)

113 (43.1)

  

 G/A

269 (45.8)

117 (44.7)

  

 A/A

68 (11.6)

32 (12.2)

1.0 (0.7–1.4)

0.9

ERCC1-rs11615, n (%)

 T/T

236 (40.9)

105 (40.9)

  

 C/T

263 (45.6)

111 (43.1)

  

 C/C

78 (13.5)

41 (16.0)

1.1 (0.7–1.4)

0.9

ERCC2-rs238406, n (%)

 C/C

176 (30.9)

73 (29.0)

  

 C/A

281 (49.4)

130 (51.6)

  

 A/A

112 (19.7)

49 (19.4)

1.1 (0.6–1.2)

0.7

ERCC2-rs13181, n (%)

 A/A

219 (37.9)

99 (39.0)

  

 A/C

283 (49.0)

124 (48.8)

  

 C/C

76 (13.1)

31 (12.2)

1.1 (0.8–1.5)

0.7